GlassScriptPhysician profile
Jenna Stoddard
NPI 1184101602
$857.51
in general payments reported to CMS, 2019-2025
15 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $101 · 2021: $212 · 2022: $86.31 · 2023: $26.40 · 2024: $35.03 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $189.37 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $187.26 | 2019-2020 | |
| Biotissue Holdings INC. | $144.15 | 2020-2025 | |
| Johnson & Johnson Vision Care, INC. | $102.22 | 2019 | |
| Abbvie INC. | $45.12 | 2023-2024 | Alphagan P, Lumigan |
| Novartis Pharmaceuticals Corporation | $28.79 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $28.75 | 2025 | Ultomiris |
| Bausch & Lomb Americas INC. | $22.81 | 2022 | |
| Oyster Point Pharma, INC. | $22.03 | 2022 | |
| Kala Pharmaceuticals, INC. | $19.48 | 2021 | |
| Coopervision INC. | $16.31 | 2024 | Onefit Contact Lens |
| Allergan, INC. | $14.63 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.49 | 2020 | |
| Oasis Medical, INC. | $13.33 | 2022 | |
| Visioneering Technologies, INC. | $8.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Stoddard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.